Učitavanje...
β2-adrenoreceptor medications and risk of Parkinson disease
OBJECTIVE: A recent study observed a two-fold greater risk of Parkinson disease (PD) in relation to the β2-adrenoreceptor antagonist propranolol and a markedly lower risk of PD for the β2-adrenoreceptor agonist salbutamol. We examined whether confounding by clinical indication for these medications,...
Spremljeno u:
| Izdano u: | Ann Neurol |
|---|---|
| Glavni autori: | , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2018
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6881195/ https://ncbi.nlm.nih.gov/pubmed/30225948 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ana.25341 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|